A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours

by Ang, Yvonne L. E., Ho, Gwo Fuang, Soo, Ross A., Sundar, Raghav, Tan, Sing Huang, Yong, Wei Peng, Ow, Samuel G. W., Lim, Joline S. J., Chong, Wan Qin, Soe, Phyu Pyar, Tai, Choo, Wang, Lingzhi, Goh, Boon Cher, Lee, Soo-Chin
Published 2020

Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies

by Wong, Andrea, Soo, Ross A., Tan, Daniel, Lee, Soo Chin, Lim, Joline S J, Marban, P.C., Kong, Li Ren, Lee, Youngjoo, Wang, Lingzhi, Thuya, Win Lwin, Soong, R., Yee, M.Q., Chin, T.M., Cordero, Maricel Tiemsim, Asuncion, Bernadette Reyna, Pang, B., Pervaiz, Shazib, Hirpara, Jayshree L., Sinha, Arvind, Xu, W.W., Yuasa, M., Tsunoda, T., Motoyama, M., Yamauchi, T., Goh, Boon Cher
Published 2016